PRVA vs. GH, RDNT, BTSG, SHC, OPCH, WGS, HTFL, VCYT, SGRY, and CON
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Veracyte (VCYT), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.
Privia Health Group vs. Its Competitors
Privia Health Group (NASDAQ:PRVA) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.
94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 10.7% of Privia Health Group shares are held by insiders. Comparatively, 6.1% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Privia Health Group currently has a consensus target price of $28.58, indicating a potential upside of 19.59%. Guardant Health has a consensus target price of $65.86, indicating a potential upside of 4.78%. Given Privia Health Group's higher probable upside, equities analysts plainly believe Privia Health Group is more favorable than Guardant Health.
Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Privia Health Group has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.
Privia Health Group has a net margin of 0.78% compared to Guardant Health's net margin of -49.93%. Privia Health Group's return on equity of 2.13% beat Guardant Health's return on equity.
In the previous week, Guardant Health had 4 more articles in the media than Privia Health Group. MarketBeat recorded 7 mentions for Guardant Health and 3 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.86 beat Guardant Health's score of 0.28 indicating that Privia Health Group is being referred to more favorably in the media.
Summary
Privia Health Group beats Guardant Health on 12 of the 17 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 10/7/2025 by MarketBeat.com Staff
